EFFICACY OF AZACITIDINE TO RESTORE FULL DONOR CHIMERISM IN MDS OR AML PATIENTS AFTER ALLOGENEIC HSCT: A THERAPEUTIC OPTION FOR TREATMENT OF EARLY RELAPSE

被引：0
|
作者：
Gozzini, A. [1 ]
Guidi, S. [1 ]
Nozzoli, C. [1 ]
Saccardi, R. [1 ]
Santini, V. [2 ]
Donnini, I. [1 ]
Angarano, R. [1 ]
Boncompagni, R. [1 ]
Sanna, A. [1 ]
Bosi, A. [2 ]
机构：
[1] Univ Florence, Hematol, AOU CAREGGI, Florence, Italy
[2] Univ Florence, Hematol, Florence, Italy
来源：
BONE MARROW TRANSPLANTATION | 2014年 / 49卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
PH-P171
引用
收藏
页码：S182 / S182
页数：1
相关论文
共 50 条
  • [1] Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trial
    U Platzbecker
    M Wermke
    J Radke
    U Oelschlaegel
    F Seltmann
    A Kiani
    I-M Klut
    H Knoth
    C Röllig
    J Schetelig
    B Mohr
    X Graehlert
    G Ehninger
    M Bornhäuser
    C Thiede
    Leukemia, 2012, 26 : 381 - 389
  • [2] Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trial
    Platzbecker, U.
    Wermke, M.
    Radke, J.
    Oelschlaegel, U.
    Seltmann, F.
    Kiani, A.
    Klut, I-M
    Knoth, H.
    Roellig, C.
    Schetelig, J.
    Mohr, B.
    Graehlert, X.
    Ehninger, G.
    Bornhaeuser, M.
    Thiede, C.
    LEUKEMIA, 2012, 26 (03) : 381 - 389
  • [3] Strategies of prevention of disease relapse in MDS/AML patients after allogeneic HSCT
    Platzbecker, U.
    ONKOLOGIE, 2013, 36 : 91 - 91
  • [4] 5-azacitidine is a possible therapeutic option for patients with relapsed AML or MDS after allogeneic stem cell transplantation
    Steckel, N. K.
    Gromke, T.
    Hegerfeldt, Y.
    Hlinka, M.
    Koldehoff, M.
    Ditschkowski, M.
    Elmaagacli, A.
    Beelen, D. W.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S540 - S541
  • [5] Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation
    Schroeder, T.
    Czibere, A.
    Platzbecker, U.
    Bug, G.
    Uharek, L.
    Luft, T.
    Giagounidis, A.
    Zohren, F.
    Bruns, I.
    Wolschke, C.
    Rieger, K.
    Fenk, R.
    Germing, U.
    Haas, R.
    Kroeger, N.
    Kobbe, G.
    LEUKEMIA, 2013, 27 (06) : 1229 - 1235
  • [6] Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation
    T Schroeder
    A Czibere
    U Platzbecker
    G Bug
    L Uharek
    T Luft
    A Giagounidis
    F Zohren
    I Bruns
    C Wolschke
    K Rieger
    R Fenk
    U Germing
    R Haas
    N Kröger
    G Kobbe
    Leukemia, 2013, 27 : 1229 - 1235
  • [7] Efficacy and tolerablity of azacitidine treatment in patients with MDS, AML and CMML
    Biedma, A.
    Avellaneda, C.
    Berruga, J.
    Tallon, D.
    Ferrer, C.
    Anguita, M.
    LEUKEMIA RESEARCH, 2013, 37 : S97 - S97
  • [8] EFFICACY AND TOLERABLITY OF AZACITIDINE TREATMENT IN PATIENTS WITH MDS, AML AND CMML
    Biedma, A.
    Avellaneda, C.
    Berruga, J.
    Tallon, D.
    Ferrer, C.
    Anguita, M.
    HAEMATOLOGICA, 2013, 98 : 589 - 589
  • [9] Administering Leukemia-Directed Donor Lymphocytes to Patients with AML or MDS to Prevent or Treat Post-Allogeneic HSCT Relapse
    Lulla, Premal
    Naik, Swati
    Tzannou, Ifigeneia
    Mukhi, Shivani
    Kuvalekar, Manik
    Robertson, Catherine
    Ramos, Carlos A.
    Carrum, George
    Kamble, Rammurti T.
    Gee, Adrian P.
    Grilley, Bambi
    Brenner, Malcolm K.
    Heslop, Helen E.
    Vera, Juan F.
    Leen, Ann M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [10] Salvage Therapy with Azacitidine Increases Regulatory T Cells in Patients with AML or MDS and Early Relapse After Allogeneic Blood Stem Cell Transplantation
    Schroeder, Thomas
    Froebel, Julia
    Cadeddu, Ron Patrick
    Czibere, Akos G.
    Dienst, Ariane
    Zipperer, Esther
    Platzbecker, Uwe
    Bug, Gesine
    Uharek, Lutz
    Fenk, Roland
    Germing, Ulrich
    Kroeger, Nicolaus
    Haas, Rainer
    Kobbe, Guido
    BLOOD, 2012, 120 (21)
12345